Appeal court overturns UK puberty blockers ruling for under-16s

Read More

Appeal court overturns UK puberty blockers ruling for under-16s

Tavistock and Portman NHS foundation trust wins challenge over case brought by Keira Bell last year

Legal affairs correspondent

Last modified on Fri 17 Sep 2021 10.29 EDT

The court of appeal has overturned a controversial judgment that children under the age of 16 considering gender reassignment are unlikely to be mature enough to give informed consent to be prescribed puberty-blocking drugs.

Tavistock and Portman NHS foundation trust, which runs NHS England’s only gender identity development service for children, challenged a high court ruling last year in a case brought against the service by Keira Bell, a 24-year-old woman who began taking puberty blockers when she was 16 before detransitioning. The other applicant was the unnamed mother of a teenage autistic girl on the waiting list for treatment.

The three high court judges had also said the doctors of teenagers under 18 may need to consult the courts for authorisation for medical intervention. As a result of the decision, the Tavistock suspended new referrals for puberty blockers and cross-sex hormones for the under-16s.

The court of appeal’s judgment was published on Friday.

More details to follow…

Related articles

You may also be interested in

Pelosi: Harris Won Dems’ ‘Open Primary’

Vice President Kamala Harris became the Democratic presidential nominee because she won “an open primary,” according to former House Speaker Nancy Pelosi, D-Calif.[#item_full_content]

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.